Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002935643 | SCV003666271 | uncertain significance | Inborn genetic diseases | 2022-12-06 | criteria provided, single submitter | clinical testing | The c.838C>A (p.P280T) alteration is located in exon 3 (coding exon 2) of the TRIP12 gene. This alteration results from a C to A substitution at nucleotide position 838, causing the proline (P) at amino acid position 280 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Revvity Omics, |
RCV003140189 | SCV003821508 | uncertain significance | Clark-Baraitser syndrome | 2020-06-22 | criteria provided, single submitter | clinical testing |